bazedoxifene has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Huo, S; Li, C; Li, S; Lin, J; Lin, L; Liu, T; Luo, P; Lv, J; Ma, H; Shi, W; Tao, J; Yan, D; Zhai, M; Zhang, C | 1 |
| Hashimoto, T; Kitazato, KT; Korai, M; Maekawa, H; Miyamoto, T; Nagahiro, S; Satomi, J; Tada, Y; Yagi, K | 1 |
2 other study(ies) available for bazedoxifene and Hypertension
| Article | Year |
|---|---|
Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.
Topics: Animals; Autophagy; Cytokine Receptor gp130; Disease Models, Animal; Gene Expression Regulation; Heart; Humans; Hypertension; Indoles; Interleukin-6; Mice; Rats; STAT3 Transcription Factor; Ventricular Remodeling | 2020 |
Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats.
Topics: Animals; Blood Pressure; Cerebral Arteries; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Hypertension; Indoles; Intracranial Aneurysm; Matrix Metalloproteinase 2; Ovariectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salts; Selective Estrogen Receptor Modulators; Tissue Inhibitor of Metalloproteinase-2 | 2017 |